Daesung Microbiological Labs. Co. Ltd

Researches and manufactures veterinary vaccines and medicines for livestock, fish, and canines.

036480 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 경기도 의왕시 덕영대로 103, 의왕시
Website:: https://eng.dsmbio.co.kr/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Daesung Microbiological Labs. Co., Ltd. is a veterinary pharmaceutical company engaged in the research, manufacture, and sale of animal medicines. Established in 1968, the company has over half a century of experience contributing to the health of the livestock industry. Its product portfolio includes a wide range of vaccines, antibiotics, and other therapeutic drugs for various animals, including swine, poultry, cattle, canines, and fish. As a leading vaccine manufacturer with KGMP (Korean Good Manufacturing Practice) certification, the company focuses on producing high-quality products aimed at disease prevention and promoting animal welfare.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Daesung Microbiological Labs. Co. Ltd and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Daesung Microbiological Labs. Co. Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Daesung Microbiological Labs. Co. Ltd via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
MYUNGMOON PHARM CO.,LTD Develops, manufactures, and commercializes prescription & OTC medicines for global markets.	South Korea	017180
Nanexa AB Develops long-acting injectables using its proprietary nanotechnology for its own pipeline and partners.	Sweden	NANEXA
Nanobiotix Develops a first-in-class radioenhancer to amplify radiotherapy's effect directly within tumors.	France	NANO
Nanoform Finland OYJ Pharma tech firm engineering nanoparticles to enhance drug performance and development.	Finland	NANOFH
NanoGroup S.A. Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.	Poland	NNG
NanoRepro AG Develops and distributes rapid diagnostic self-tests for early disease detection.	Germany	NN6
NATAC Develops sustainable plant extracts for nutraceutical, pharma, food, and animal nutrition industries.	Spain	NAT
Naturalendo Tech Co., Ltd Biotech R&D of natural ingredients for health and wellness solutions.	South Korea	168330
Naturland Holding PLC A Hungarian company providing full-scale pharmaceutical manufacturing from R&D to sales.	United Kingdom	NATUR
NeoImmuneTech, Inc. Develops NT-I7, a T cell-amplifying immunotherapy for cancer and infectious diseases.	United States of America	950220